Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Sage

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1982
[Cytologic grade, a prognostic factor in breast cancer]J Mouriquand, M Bolla, P Gabelle, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|December 21, 1981
[Tamoxifen induced fluorescence as a marker of hormone receptors: cytological study of fine needle biopsy of malignant breast tumors in treated women]J Mouriquand, C Mouriquand, J C Sage, et al.
Cancer Research|August 1, 1983
Tamoxifen-induced fluorescence as a marker of human breast tumor cell responsiveness to hormonal manipulations: correlation with progesterone receptor content and ultrastructural alterationsJ Mouriquand, M Jacrot, J Louis, et al.
La Nouvelle Presse Medicale|September 24, 1979
[Cytoprognosis in the pretherapeutic assessment of carcinoma of the breast. 192 cases. (author's transl)]J Mouriquand, J P Bodin, J C Sage, et al.
Journal of Clinical Pathology|May 1, 1986
Value of cytoprognostic classification in breast carcinomasJ Mouriquand, M Gozlan-Fior, D Villemain, et al.
Human Reproduction (Oxford, England)|March 16, 2006
Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb studyJ A Huirne, J N Hugues, C Pirard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1982
[Cytologic grade, a prognostic factor in breast cancer]J Mouriquand, M Bolla, P Gabelle, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|December 21, 1981
[Tamoxifen induced fluorescence as a marker of hormone receptors: cytological study of fine needle biopsy of malignant breast tumors in treated women]J Mouriquand, C Mouriquand, J C Sage, et al.
Cancer Research|August 1, 1983
Tamoxifen-induced fluorescence as a marker of human breast tumor cell responsiveness to hormonal manipulations: correlation with progesterone receptor content and ultrastructural alterationsJ Mouriquand, M Jacrot, J Louis, et al.
La Nouvelle Presse Medicale|September 24, 1979
[Cytoprognosis in the pretherapeutic assessment of carcinoma of the breast. 192 cases. (author's transl)]J Mouriquand, J P Bodin, J C Sage, et al.
Journal of Clinical Pathology|May 1, 1986
Value of cytoprognostic classification in breast carcinomasJ Mouriquand, M Gozlan-Fior, D Villemain, et al.
Human Reproduction (Oxford, England)|March 16, 2006
Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb studyJ A Huirne, J N Hugues, C Pirard, et al.
Pageof 1